Regulatory

On September 23, 2024, trade groups and industry stakeholders testified before the New Jersey Legislature’s Assembly Health Committee in opposition to assembly bill A1848, which would prohibit the sale of weight management and muscle building supplements to minors.

The natural products manufacturer introduced three supplement products in the new line.

The U.S. Hemp Roundtable submitted comments to California’s Office of Administrative Law (OAL) on September 16th, urging the agency to overrule emergency regulations proposed by Governor Gavin Newsom and the California Department of Public Health (CDPH).

The Attorney General's office says that non-alcoholic beverages with hemp-derived tetrahydrocannabinol (THC) with concentrations of delta-9 THC of no more than 0.3% are legal in South Carolina, assuming you can verify they meet this threshold.

The bill regulates the sale and distribution of products containing synthetic THC, though some challenges remain to be resolved.

The ingredient is also approved to claim as a health benefit that it “helps stimulate the growth of healthy bacteria (such as bifidobacteria) in the intestine/gut.”

The regulations would ban any hemp-derived food, beverage and dietary products from having any THC levels and impose an age restriction of 21 to purchase these products.

The Missouri Hemp Trade Association has filed a lawsuit in the Cole County Circuit Court seeking to prevent the Missouri DHSS from designating food and beverage products containing psychoactive cannabinoids derived from hemp as adulterated and implementing an embargo.

Missouri’s Department of Health and Senior Services (DHSS) is on track to “embargo and condemn” products that contain intoxicating cannabinoids starting September 1, 2024 in accordance to an executive order signed by the state’s governor, Michael L. Parsons.

The Natural Products Association (NPA; Washington, D.C.) has announced that they filed a lawsuit against the U.S. Food and Drug Administration (FDA) for its retroactive application of the Food, Drug, and Cosmetic Act (FD&C) against Nicotinamide Mononucleotide (NMN).

The Natural and Non-Prescription Health Products Directorate (NNPHD) of Health Canada has granted PLT Health Solutions an updated license to market its AprèsFlex 5-Day Joint Support Ingredient in Canada.

The Council for Responsible Nutrition has replied to a brief from the NYAG's office in response CRN's appeal of the court's dismissal of its motion for a preliminary injunction. The injunction would have halted enforcement of the law, banning the sale of weight management supplements to minors, until the outcome of the lawsuit.

California Assembly Bill 2223 has failed to pass the State Senate.

A California assembly bill (AB-82) that would ban the sale of weight management supplements to minors has failed to advance in the Senate.

The new plant-based stimulant promotes brain health for high-stress situations.

California's Assembly Bill 2223 has prompted criticism of its proposed restrictions on intoxicating hemp products.

Senate Majority Whip Dick Durbin has introduced the Dietary Supplement Listing Act of 2024, which would implement a mandatory product listing (MPL) for manufacturers of dietary supplements.

The U.S. Food and Drug Administration and Federal Trade Commission have jointly issued warning letters to five companies for selling copycat food products containing delta-8 THC in violation of the Federal Food Drug and Cosmetic Act.

According to the company, this marks the first expanded use of shea stearin in new food categories since 1998.

FDA has agreed that four ingredients in Arla Foods’ Peptigen and Lacprodan ranges meet the definition for peptones in the U.S. Code of Federal Regulations, therefore permitting it for use in early life nutrition.

TamaFlex has been registered as a Health Functional Food Ingredient (HFFI) by South Korea’s Ministry of Food and Drug Safety (MFDS).

A 2013 study published in BMC Medicine titled “DNA barcoding detects contamination and substitution in North American herbal products,” has been retracted by the publication’s editor.

Bioiberica (Barcelona, Spain) has announced self-determination of GRAS (generally recognized as safe) for its Collavant n2 native (undenatured) type II collagen at 40 mg/day.

FrieslandCampina Ingredients says it is one step closer to “final nutrition fortifier” from the Chinese Ministry of Agriculture and Rural Affairs (MARA) for its Lacto-N-Tetraose (LNT) ingredient.

Safety substantiation requirements for finished cosmetic products to comply with The Modernization of Cosmetics Regulations Act (MoCRA).

ADM announced that its spore-forming probiotic DE111 (Bacillus subtilis) has received official approval from the Therapeutic Goods Administration (TGA), which is a part of the Australian Department of Health.

The authorization by the EU allows the use of ampli-D at a maximum daily dose of 10 µg in children over 11 years old and adults including pregnant and lactating women, and a maximum daily dose of 5 µg for children aged 3-10.

New York State's motion to dismiss CRN's lawsuit against the law banning the sale of weight management and muscle-building supplements to minors has been partially denied, allowing CRN to proceed with its First Amendment Claim.

According to Keraplast, independent tests show that its keratin products have trace nitrosamine levels of < 1 ppb, while the maximum allowed is 50 ppb.

The latest updates in the efforts of the Natural Products Association and the Council for Responsible Nutrition to sue New York state for its law banning the sale of weight management and muscle building supplements to minors.